Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmood Naderi

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 15, 2015
Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicleMohsen Khorashadizadeh, Masoud Soleimani, Hossein Khanahmad, et al.
Cell Biology International|October 19, 2010
Stem cell-conditioned medium does not protect against kidney failureYousof Gheisari, Naser Ahmadbeigi, Mahmood Naderi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 7, 2012
Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole bloodMahmood Naderi, Mahdi Paryan, Kayhan Azadmanesh, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2019
ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapyMasoud Sotoudeh, Ramin Shakeri, Sanford M Dawsey, et al.
Expert Opinion on Therapeutic Targets|December 9, 2023
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapyMasoud Sotoudeh, Vahid Mansouri, Ramin Shakeri, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2015
Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancerVahid Haghpanah, Parviz Fallah, Rezvan Tavakoli, et al.
Iranian Journal of Microbiology|January 30, 2014
Isolation of Asian endemic and livestock associated clones of methicillin resistant Staphylococcus aureus from ocular samples in Northeastern IranSeyed Asghar Havaei, Amir Azimian, Hosein Fazeli, et al.
Cancer Cell International|December 9, 2022
BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional cultureHilda Samimi, Rezvan Tavakoli, Parviz Fallah, et al.
Archives of Iranian Medicine|March 2, 2019
Generation of CD19-Targeted Chimeric Antigen Receptor T CellsJafar Kiani, Mahmood Naderi, Monireh Torabi-Rahvar, et al.
Acta Medica Iranica|March 12, 2017
Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling PathwaysHilda Samimi, Parviz Fallah, Alireza Naderi Sohi, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 15, 2015
Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicleMohsen Khorashadizadeh, Masoud Soleimani, Hossein Khanahmad, et al.
Cell Biology International|October 19, 2010
Stem cell-conditioned medium does not protect against kidney failureYousof Gheisari, Naser Ahmadbeigi, Mahmood Naderi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 7, 2012
Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole bloodMahmood Naderi, Mahdi Paryan, Kayhan Azadmanesh, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2019
ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapyMasoud Sotoudeh, Ramin Shakeri, Sanford M Dawsey, et al.
Expert Opinion on Therapeutic Targets|December 9, 2023
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapyMasoud Sotoudeh, Vahid Mansouri, Ramin Shakeri, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2015
Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancerVahid Haghpanah, Parviz Fallah, Rezvan Tavakoli, et al.
Iranian Journal of Microbiology|January 30, 2014
Isolation of Asian endemic and livestock associated clones of methicillin resistant Staphylococcus aureus from ocular samples in Northeastern IranSeyed Asghar Havaei, Amir Azimian, Hosein Fazeli, et al.
Cancer Cell International|December 9, 2022
BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional cultureHilda Samimi, Rezvan Tavakoli, Parviz Fallah, et al.
Archives of Iranian Medicine|March 2, 2019
Generation of CD19-Targeted Chimeric Antigen Receptor T CellsJafar Kiani, Mahmood Naderi, Monireh Torabi-Rahvar, et al.
Acta Medica Iranica|March 12, 2017
Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling PathwaysHilda Samimi, Parviz Fallah, Alireza Naderi Sohi, et al.
Pageof 5